Quantum Financial Advisors LLC acquired a new stake in Aflac Incorporated (NYSE:AFL – Free Report) in the fourth quarter, according to the company in its most recent disclosure with the SEC. The institutional investor acquired 5,745 shares of the financial services provider’s stock, valued at approximately $634,000.
A number of other large investors also recently added to or reduced their stakes in the business. JGP Wealth Management LLC lifted its stake in Aflac by 1.5% in the fourth quarter. JGP Wealth Management LLC now owns 80,925 shares of the financial services provider’s stock worth $8,924,000 after purchasing an additional 1,185 shares during the last quarter. Avanza Fonder AB increased its holdings in shares of Aflac by 16.5% in the fourth quarter. Avanza Fonder AB now owns 39,863 shares of the financial services provider’s stock worth $4,396,000 after buying an additional 5,639 shares during the period. Rialto Wealth Management LLC lifted its stake in shares of Aflac by 530.7% in the 4th quarter. Rialto Wealth Management LLC now owns 2,119 shares of the financial services provider’s stock valued at $234,000 after acquiring an additional 1,783 shares during the last quarter. Somerset Trust Co boosted its holdings in Aflac by 0.3% during the 4th quarter. Somerset Trust Co now owns 54,275 shares of the financial services provider’s stock valued at $5,985,000 after acquiring an additional 143 shares during the period. Finally, SG Americas Securities LLC boosted its holdings in Aflac by 3.7% during the 4th quarter. SG Americas Securities LLC now owns 149,917 shares of the financial services provider’s stock valued at $16,531,000 after acquiring an additional 5,410 shares during the period. Hedge funds and other institutional investors own 67.44% of the company’s stock.
Aflac Price Performance
AFL opened at $106.55 on Tuesday. The company has a debt-to-equity ratio of 0.29, a quick ratio of 0.11 and a current ratio of 0.11. Aflac Incorporated has a 52-week low of $96.95 and a 52-week high of $119.32. The stock has a market capitalization of $54.89 billion, a PE ratio of 15.49, a price-to-earnings-growth ratio of 3.48 and a beta of 0.66. The stock’s 50 day moving average price is $111.31 and its 200-day moving average price is $110.37.
Insider Activity
In related news, Director Charles D. Lake II sold 15,590 shares of the stock in a transaction dated Wednesday, March 11th. The shares were sold at an average price of $109.93, for a total value of $1,713,808.70. Following the completion of the transaction, the director directly owned 62,237 shares of the company’s stock, valued at $6,841,713.41. This represents a 20.03% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Also, major shareholder Post Holdings Co. Ltd. Japan sold 10,100 shares of Aflac stock in a transaction that occurred on Thursday, March 19th. The shares were sold at an average price of $107.41, for a total value of $1,084,841.00. Following the sale, the insider directly owned 52,078,600 shares in the company, valued at approximately $5,593,762,426. The trade was a 0.02% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Over the last ninety days, insiders sold 189,077 shares of company stock valued at $20,779,860. Corporate insiders own 0.80% of the company’s stock.
Wall Street Analyst Weigh In
AFL has been the subject of several recent research reports. Mizuho set a $107.00 price objective on Aflac in a research report on Monday, February 9th. Weiss Ratings reaffirmed a “buy (b+)” rating on shares of Aflac in a research note on Monday, December 22nd. TD Cowen reiterated a “hold” rating on shares of Aflac in a report on Monday, December 22nd. Raymond James Financial reissued an “outperform” rating and set a $119.00 price target (up from $110.00) on shares of Aflac in a research report on Tuesday, December 30th. Finally, Morgan Stanley set a $120.00 price objective on shares of Aflac in a research report on Monday, December 15th. Three investment analysts have rated the stock with a Buy rating, six have issued a Hold rating and three have assigned a Sell rating to the company’s stock. According to data from MarketBeat, Aflac has a consensus rating of “Hold” and an average target price of $111.73.
Check Out Our Latest Stock Analysis on AFL
Aflac Company Profile
Aflac Incorporated (American Family Life Assurance Company of Columbus) is a provider of supplemental insurance products designed to help policyholders manage out-of-pocket health care and living expenses. The company underwrites a range of individual and group policies that typically pay cash benefits directly to insureds when covered events occur, enabling greater financial flexibility for medical treatment, hospital stays, critical illness, and related costs. Aflac’s product mix includes supplemental health insurance, life insurance and other specialty coverages intended to complement primary medical plans.
Founded in the mid-20th century and headquartered in Columbus, Georgia, Aflac distributes its products through a combination of employer-sponsored programs, independent brokers and agents, and direct marketing.
Recommended Stories
Want to see what other hedge funds are holding AFL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Aflac Incorporated (NYSE:AFL – Free Report).
Receive News & Ratings for Aflac Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aflac and related companies with MarketBeat.com's FREE daily email newsletter.
